Pages that link to "Q71114381"
Jump to navigation
Jump to search
The following pages link to Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific (Q71114381):
Displaying 10 items.
- CYP24A1 inhibition enhances the antitumor activity of calcitriol (Q34132307) (← links)
- Antiproliferative action of vitamin D. (Q34566267) (← links)
- Enhancement by other compounds of the anti-cancer activity of vitamin D(3) and its analogs. (Q35841859) (← links)
- Vitamin D signalling pathways in cancer: potential for anticancer therapeutics (Q36919979) (← links)
- Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation (Q38108294) (← links)
- Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer. (Q53524818) (← links)
- Vitamin D in prostate cancer. (Q55024961) (← links)
- Calcitriol and cancer therapy: A missed opportunity (Q61023219) (← links)
- Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3 (Q73635112) (← links)
- Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed (Q77734389) (← links)